MedTrace Logo

Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19)

NCT04365322 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2020-07-14

No results posted yet for this study

Summary

SARS-CoV-2, has caused an international outbreak of respiratory illness termed Covid-19. The investigators used peptides derived from SARS-CoV-2 virus, to study viral-specific immune responses. COV-CREM is a French prospective monocentric study that will evaluate viral-specific cell responses in positive patients for SARS-CoV-2 on the basis of (RT-PCR) assay performed in respiratory tract sample tested by our local Center for Disease Control.

Conditions

Interventions

OTHER

Additional biological samples

Peripheral Blood Mononuclear Cell (PBMC) and plasma will be collected.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-20
Primary Completion
2020-09-01
Completion
2025-04-20

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04365322 on ClinicalTrials.gov